In accordance with its anti-cancer features noted in other cancer types 9, 11, 14, our results demonstrated that addition of SFN-Cys reduced the viability of both HSC-3 and SCC-9 cells in a dose-dependent manner (Figure 1), suggesting an oncostatic role of SFN-Cys in OSCC. Here, SFN is linked to cancer.